Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin - Martinot-Peignoux, M; Stern, C; Maylin, S (Hepatology, 2010)
et al.